Email this article Semax as a Universal Drug for Therapy and Research
- Authors: Koroleva S.V.1, Myasoedov N.F.1
-
Affiliations:
- Institute of Molecular Genetics, Russian Academy of Sciences
- Issue: Vol 45, No 6 (2018)
- Pages: 589-600
- Section: Animal and Human Physiology
- URL: https://journals.rcsi.science/1062-3590/article/view/182816
- DOI: https://doi.org/10.1134/S1062359018060055
- ID: 182816
Cite item
Open Access
Access granted
Subscription Access
Abstract
In this review, based on published experimental and clinical data (1980‒2016), a comparative analysis of the structures and effects of Semax (peptide drug) and its analogue fragments was carried out. The effect of these oligopeptides on various body systems is examined. The multiple effects of Semax for a number of diseases have been collected for a single scheme of corrective processes. The rationale for the long-term therapeutic effects of this peptide drug is presented. A comparative analysis of the temporal dynamics of the expression of certain genes is carried out.
About the authors
S. V. Koroleva
Institute of Molecular Genetics, Russian Academy of Sciences
Author for correspondence.
Email: svr.koroleva@gmail.com
Russian Federation, Moscow, 123182
N. F. Myasoedov
Institute of Molecular Genetics, Russian Academy of Sciences
Email: svr.koroleva@gmail.com
Russian Federation, Moscow, 123182
